Back to Search
ULKA VAISHAMPAYAN, MD
MD
Internal Medicine Physician
NPI: 1659318640IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301062981(MI)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
4301062981(MI)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1993
Research & Publications (20)
Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer.
PMID 19447430·J Urol·2009
3-trial
Update in systemic therapy of prostate cancer: improvement in quality and duration of life.
PMID 18279067·Expert Rev Anticancer Ther·2008
6-review
Lycopene and soy isoflavones in the treatment of prostate cancer.
PMID 17927495·Nutr Cancer·2007
3-trial
Phase II trial of pegylated interferon and thalidomide in malignant metastatic melanoma.
PMID 17893524·Anticancer Drugs·2007
3-trial
Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.
PMID 16937078·Invest New Drugs·2007
3-trial
Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study.
PMID 16138364·Cancer·2005
3-trial
Phase II trial of fenretinide in advanced renal carcinoma.
PMID 15744595·Invest New Drugs·2005
3-trial
Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma.
PMID 15577431·Am J Clin Oncol·2004
3-trial
Racial disparity in incidence patterns and outcome of kidney cancer.
PMID 14665346·Urology·2003
8-other
An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer.
PMID 12475668·Urology·2002
3-trial
Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha.
PMID 12473578·Clin Cancer Res·2002
3-trial
Unusual hematologic malignancies. Case 2. Mediastinal germ cell tumor, malignant histiocytosis, and acute leukemia.
PMID 12202675·J Clin Oncol·2002
5-case
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies.
PMID 12062611·Int J Radiat Oncol Biol Phys·2002
8-other
Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation.
PMID 12025224·Cancer Invest·2002
8-other
The evolving role of systemic therapy in high risk prostate cancer: strategies for cure in the 21st century.
PMID 12007976·Crit Rev Oncol Hematol·2002
6-review
Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy.
PMID 11722412·Br J Haematol·2001
5-case
Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma.
PMID 11505395·Cancer·2001
3-trial
Adjuvant chemo-/hormonal therapy trials for locally advanced prostate cancer.
PMID 11122871·Curr Oncol Rep·2000
6-review
Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.
PMID 11106233·Clin Cancer Res·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4000
Quick Facts
- NPI
- 1659318640
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile